What are the barriers, facilitators, and support needs affecting clinicians' recognition and monitoring of antipsychotic-induced hyperprolactinemia in mental health services?
There are significant barriers, including communication gaps and a lack of consensus guidelines, affecting the recognition and monitoring of antipsychotic-induced hyperprolactinemia in mental health services. Support needs include routine monitoring and clear communication between services and healthcare providers.
Authors
- Tripdatabase
Publication Details
- Journal
- Zenodo (CERN European Organization for Nuclear Research)
- Published
- 2026-11-09
- DOI
- https://doi.org/10.5281/zenodo.24084319
- Primary Topic
- Schizophrenia research and treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00